• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Scientists discover origin of cell mask that hides stomach cancer

Bioengineer by Bioengineer
July 8, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A layer of cells that look like normal stomach lining on top of sites of stomach cancer can make it difficult to spot after removal of a Helicobacter pylori infection

IMAGE

Credit: Hiroshima University

A layer of cells that look like normal stomach lining on top of sites of stomach cancer can make it difficult to spot after removal of a Helicobacter pylori infection. In a recent study, researchers from Hiroshima University have uncovered the origin of this layer of cells: it is produced by the cancer tissue itself.

Helicobacter pylori (H. pylori) is a type of bacteria that lives in people’s stomachs. To survive the harsh environment these bacteria can neutralize stomach acid. H. pylori is the leading cause of stomach cancer, one of the most common types of cancer which can have a low survival rate. The bacteria cause inflammation by injecting a toxin-like substance into mucosal cells that line the stomach. This destruction and regeneration of these cells can lead to the development of stomach cancer.

In this study Professor Kazuaki Chayama, from Hiroshima University Hospital, and his team found the origins of a strange layer of cells that was present on stomach cancer sites after treatment of H. pylori. This layer, called ELA (epithelium with low-grade atypia), resembled normal mucosal cells that line the stomach and acted like a mask to hide stomach cancer. Up to now, researchers were not sure where this layer came from.

“It was very interesting scientifically to find that that cancer reoccurs even after eradicating causal bacteria.” says Chayama.

A H. pylori infection is cured after a course of antibiotics that leave reddish depression in the stomach.

“H. pylori eradication affects the regeneration of gastric mucosa. After eradication there are many reddish depressions in the stomach, most of them are not cancer. It is difficult to identify the ELA mucosa from amongst the regular mucosa.” explains Chayama.

The research group conducted a preliminary study on 10 patients after gastric operations and looked for this layer of cells. The ELA cells’ DNA was intensively studied and was found to be identical to stomach cancer cells. ELA was concluded to come from the stomach cancer tissue itself.

These findings could mean that even after getting rid of H. pylori there is still a risk of stomach cancer for some patients. Stomach cancer can be difficult to spot due to its location and the fact that the disease can progress slowly. This is not helped by ELA that masks cancer after the causal factor is removed.

Chayama stresses that clinicians should be aware of this layer, so they don’t miss potential sites of stomach cancer and that it is important for patients to continue having check-ups even after finishing treatment for H. pylori.

###

Details of the findings can be found in the team’s paper, published in the Journal of Gastroenterology on June 13.

Since its foundation in 1949, Hiroshima University has strived to become one of the most prominent and comprehensive universities in Japan for the promotion and development of scholarship and education. Consisting of 12 schools and 11 graduate schools, ranging from International Development and Cooperation to Integrated Arts and Sciences, the university has grown into one of the most distinguished research universities in Japan. English website: https://www.hiroshima-u.ac.jp/en

Media Contact
Norifumi Miyokawa
[email protected]

Related Journal Article

http://dx.doi.org/10.1007/s00535-019-01596-4

Tags: BiologycancerCell BiologyGenesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

University of Houston Scientist Develops Innovative Drug Delivery System to Combat Lupus

August 18, 2025
Decoding microRNA Regulation in T Cells Efficiently

Decoding microRNA Regulation in T Cells Efficiently

August 18, 2025

Promising Outcomes from Phase I/II Gene Therapy Trial for GM2 Gangliosidosis, Including Tay-Sachs and Sandhoff Diseases

August 18, 2025

DENND1A Drives Testosterone in Polycystic Ovary Syndrome

August 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    80 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    59 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Discovering the Brain’s Navigational Compass: New Insights into Human Navigation

Danforth Center Grants Proof-of-Concept Funding to Four Teams Driving Agricultural Innovation

University of Houston Scientist Develops Innovative Drug Delivery System to Combat Lupus

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.